Home

Gujarat Themis Biosyn Ltd PE Ratio

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PE

50.6

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Gujarat Themis Biosyn Ltd is 50.6 as of 22 Feb 15:30 PM .
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 6 on March 2020 to 48.7 on March 2024 . This represents a CAGR of 52.01% over 5 years.
  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 244.4 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

No data available

Company Fundamentals for Gujarat Themis Biosyn Ltd

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

Share Price

₹ 244.4

-0.05 (-0.02%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Gujarat Themis Biosyn Ltd

1M

1Y

3Y

5Y

Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025244.4
20 Feb 2025244.45
19 Feb 2025251.5
18 Feb 2025212.2
17 Feb 2025229.75
14 Feb 2025249.15
13 Feb 2025260.5
12 Feb 2025263.7
11 Feb 2025263
10 Feb 2025274.35

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gujarat Themis Biosyn Ltd

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Gujarat Themis Biosyn Ltd2663
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Gujarat Themis Biosyn Ltd Explained

2663

Market cap

52

Earnings

50.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Gujarat Themis Biosyn Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

Gujarat Themis Biosyn Ltd News Hub

Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter

Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended September

Read more

25 Oct 24

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 October 202

Read more

19 Oct 24

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have approved a Sch

Read more

19 Nov 24

Gujarat Themis Biosyn standalone net profit declines 0.31% in the December 2024 quarter

Net profit of Gujarat Themis Biosyn declined 0.31% to Rs 12.97 crore in the quarter ended December 2

Read more

14 Feb 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gujarat Themis Biosyn Ltd

What is the current PE Ratio of Gujarat Themis Biosyn Ltd?

The Current PE Ratio of Gujarat Themis Biosyn Ltd is 50.6 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Gujarat Themis Biosyn Ltd last year?

The PE Ratio of Gujarat Themis Biosyn Ltd was 17.2 last year, now the PE ratio is 50.6, showing a year-on-year growth of 194.2%.

What does the PE Ratio of Gujarat Themis Biosyn Ltd indicate about its stock?

The PE Ratio of Gujarat Themis Biosyn Ltd is 50.6. This ratio indicates that investors are willing to pay 50.6 times the earnings per share for each share of Gujarat Themis Biosyn Ltd.

What is the PE Ratio Growth of Gujarat Themis Biosyn Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gujarat Themis Biosyn Ltd grew by 194.2% whereas, the EPS ratio grew by 22.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions